OUAHBI DINA

Mrs. OUAHBI DINA

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
CTCaroline Truntzer
Caroline Truntzer
ODOUAHBI DINA
OUAHBI DINA
THTitouan Huppé
Titouan Huppé
DRDavid Rageot
David Rageot
AIAlis Ilie
Alis Ilie
Ghiringhelli FrançoisGhiringhelli François
Ghiringhelli François
Background/Objectives: Pancreatic ductal adenocarcinoma (PDAC) is a cancer with very poor prognosis despite early surgical management. To date, only clinical variables are used to predict outcome for decision-making about adjuvant therapy. We sought to generate a deep learning approach based on hematoxylin and eosin (H&E) or hematoxylin, eosin and saffron (HES) whole slides to predict patients’ outcome, compare these new entities with known molecular subtypes and question their biological significance; Methods: We used as a training set a retrospective private cohort of 206 patients treated by surgery for PDAC cancer and a validation cohort of 166 non-metastatic patients from The Cancer Genome Atlas (TCGA) PDAC project. We estimated a multi-instance learning survival model to predict relapse in the training set and evaluated its performance in the validation set. RNAseq and exome data from the TCGA PDAC database were used to describe the transcriptomic and genomic features associated with deep learning classification; Results: Based on the estimation of an attention-based multi-instance learning survival model, we identified two groups of patients with a distinct prognosis. There was a significant difference in progression-free survival (PFS) between these two groups in the training set (hazard ratio HR = 0.72 [0.54;0.96]; p = 0.03) and in the validation set (HR = 0.63 [0.42;0.94]; p = 0.01). Transcriptomic and genomic features revealed that the poor prognosis group was associated with a squamous phenotype. Conclusions: Our study demonstrates that deep learning could be used to predict PDAC prognosis and offer assistance in better choosing adjuvant treatment.

28 March 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
JGJérôme Giustiniani
Jérôme Giustiniani
VTVan Anh Ta
Van Anh Ta
SBSadjia Belkhelouat
Sadjia Belkhelouat
Maxime BattistellaMaxime Battistella
Maxime Battistella
ODOUAHBI DINA
OUAHBI DINA
AMAdèle De Masson
Adèle De Masson